葡萄糖神经酰胺合酶基因在多药耐药肿瘤细胞株KBV200的表达及其与肿瘤多药耐药性的关系

摘要/Abstract

摘要： 目的观察葡萄糖神经酰胺合酶(glucosylcerarnide synthase,GCS)基因在人口腔表皮样癌多药耐药细胞株KBV₂₀₀的表达及其与肿瘤多药耐药性(MDR)的关系。方法采用RT-PCR分析KBV₂₀₀及其亲本KB细胞株GCS基因表达的差异,运用MTT法分析KBV₂₀₀经糖脂合成酶抑制剂苯基棕榈酰胺吗啡丙醇(DL-PPMP)及钙离子通道阻滞剂异搏定处理前后细胞MDR的变化,应用RT-PCR技术检测KBV₂₀₀细胞耐药逆转后GCS及mdrl基因的表达。结果 KBV₂₀₀细胞GCS和mdrl基因的表达明显强于KB细胞,而KB细胞mdrl基因表达为阴性。5～25μmol/L DL-PPMP均可抑制KBV₂₀₀GCS mRNA表达,25 μmol/L时抑制强度最大;10 μmol/L异搏定即可抑制KBV₂₀₀GCS mRNA表达,15 μmol/L时抑制作用明显。DL-PPMP和异搏定均可抑制mdrl基因的表达,KBV₂₀₀经25μmol/L DL-PPMP作用48h后细胞内mdrl表达为阴性。结论异搏定和DL-PPMP对GCS和marl基因表达的抑制调节呈浓度依赖性,它们可通过抑制GCS和mdrl基因表达,逆转KBV₂₀₀对长春新碱的耐药。KBV₂₀₀GCS基因的表达与MDR存在正相关,GCS基因可能在肿瘤的多药耐药过程中起着重要作用。

Abstract: Objective To investigate the relationship between the expression of glucosylceramide synthase (GCS) mRNA in vincristine-resistant KBV₂₀₀ human cancer cell line and multidrug resistance (MDR) of the cancer cells. Methods Reverse transcriptional polymerase chain reaction (RT-PCR) was employed to analyze the differential expression of GCS mRNA between KBV₂₀₀ and KB cell lines and the changes in the mRNA expressions of GCS and mdrl gene in KBV₂₀₀ cells after reversion of MDR. The effects of de-phenyl-z-palmaitoylamino-3-morpholine-1-propanol (DL-PPMP) and verapamil in reversing MDR of the cells were evaluated by MTT assay. Results KBV₂₀₀ cells exhibited significantly increased expressions of GCS and mdrl gene, whereas mdrl gene failed to be detected in the parental KB cells. DL-PPMP within the concentrations ranging from 5 to 25 μmol/L could inhibit the expression of GCS gene, with the maximum inhibition achieved at 25 μmol/L. Verapamil at the concentration of 10 μmol/L was already sufficient to induce inhibition of GCS expression in KVB₂₀₀ cells, which was more manifest with the concentration of 15 μmol/L. DL-PPMP and verapamil were found to inhibit mdrl gene expression in KBV₂₀₀ cells at the mRNA level, and complete inhibition occurred after a 48-hour DL-PPMP treatment at 25 μmol/L. Conclusion The inhibition of GCS and mdrl gene expressions is positively correlated with the concentrations of DL-PPMP and verapamil, which can reverse MDR by inhibiting synthesis of GCS and mdrl gene, indicating the positive correlation between the expression of GCS gene and MDR in KBV₂₀₀ cells. GCS gene might play an importantrole in MDR during tumor progression.

中图分类号:

R979.1

杨泉, 张健, 汪森明, 张积仁. 葡萄糖神经酰胺合酶基因在多药耐药肿瘤细胞株KBV₂₀₀的表达及其与肿瘤多药耐药性的关系[J]. 南方医科大学学报, 2004, 24(07): 779-783.

YANG Quan, ZHANG Jian, WANG Sen-ming, ZHANG Ji-ren. Expression of glucosylceramide synthase mRNA in vincristine-resistant KBV₂₀₀ cell line in association with multidrug resistance[J]. Journal of Southern Medical University, 2004, 24(07): 779-783.

参考文献

[1] 张晓红,张福荣,籍秀娟,等.KB细胞耐药株的建立及其耐药机理的探讨[J].药学学报,1994,29(4):246.
[2] Liu YY, HanTY, Giuliano AE, et al. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance[J]. J Biol Chem, 2000, 275(10): 7138-43.
[3] Radin NS. Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come [J]. Eur J Biochem, 2001,268(2): 193-204.
[4] Lavie Y, Cao Ht, Volner A, et al. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylatiun in human cancer cells[J]. J Biol Chem, 1997, 272(3): 1682-7.
[5] Liu YY, FanTY, Crtuliano AE, et al. Ceramide glycosylation poteintiates cellular multidrug resistance[J]. FASEB J, 2001, 15(3): 719-30.
[6] Liu YY, Han TY, Giuliano AE, et al. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells [J]. J Biol Chem,1999, 274(2): 1140-6.
[7] Norman SR. Chemotherapy by slowing glycosphingolipid synthesis[J]. Biochem Pharmacol, 1999, 57(6): 589-95.
[8] Lucci A, Han TY, Liu YY, et al. Modification ofceramide metabolism increases cancer cell sensitivity to cytotoxics[J]. Int J Oncol, 1999,15(3):541-6.
[9] Siets ma H, Ueldman R J, Kok JW. The involvement ofsphingolipids in multidrug resistance[J]. J Membr Biol, 2001, 181(3): 153-62.
[10] 郑刚,张积仁,刘发全.脂质体介导α1,4-Gal T反义寡核苷酸对人脑胶质瘤细胞系SWO-38的作用[J].第一军医大学学报,2002,20(4):44-7.Zheng G, Zhang JR, Liu FQ. Effects of lipofectin-mediated α1, 4-Gal T antisense oligonucleotide on human glioma cell line SWO-38[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2002, 20(4): 44-7.
[11] 张世忠,张健,张积仁.脑胶质瘤中性鞘糖脂抗原的初步研究[J].中华神经外科杂志,1998,14(1):34-6.Zhang SZ, Zhang J, Zhang JR. Purification and analysis of glycosphingolipids from human gliomas [J]. Chin J Neurosurg, 1998, 14(1):34-6.
[12] 张健,张宗城,李鹏,等.红细胞糖苷脂可以抑制在体外培养的人脑胶质瘤细胞突起的形成[J].第一军医大学学报,2000,20(1):44-7.Zhang J, Zhang ZC, Li P, et al. Inhibition effect of globoside on the protuberance in human glioma cells by globoside [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2000, 20(1): 44-7.
[13] 张健,张积仁,袁亚维.中性鞘糖脂在KBV200细胞的表达及其与多药耐药性的关系[J].中华肿瘤杂志,2001,23(2):111-4.Zhang J, Zhang JR, Yuan YW. Investigation on the relationship between MDR and expression of N-giycosphingolipids in vincristine resistant KBV200 cell line[J]. Chin J Oncol, 2001, 23 (2): 111-4.
[14] ACluer RH, Gross SK. Biosynthesis of neutral glycosphingolipids in kidney slices from male and female mice[J]. Lipid Res, 1985, 26:593-9.
[15] Skouteris GG, Schroder CH. c-myc and max interactions in quiescent and mitogen-stimulated primary hepatocytes [J]. Exp Cell Res,1996, 225(2): 237-44.
[16] Abe A, Tnokuchi J, Jimbo M, et at. Improved inhibitors of glucosylceramide synthase[J]. Biochem, 1992, I11(2): 191.
[17] Lavie Y, Cao H, Bursten SL, et al. Accumulation of glucosylceramides in multidmg resistant cancer cells[J]. J Biol Chem, 1996,271(32): 19530-6.
[18] Cotran RS. Oncogene and cancer bobbins pathologic basis of disease[M]. 5th ed .Harcourt Asia: Saunders WB, 1994. 259-62.
[19] 陈俊,袁亚维,张积仁,等.耐药乳腺癌MCF-7/Adr细胞c-myc的表达上调及与耐药的关系[J].第一军医大学学报,2002,22(2):124-6.Chen J,Yuan YW, Zhang JR, et al. Up-regulation of c-myc expression in MCF-7/Adr human breast cancer cells and its association with resistance against doxorubicin[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2002, 22(2): 124-6.

葡萄糖神经酰胺合酶基因在多药耐药肿瘤细胞株KBV₂₀₀的表达及其与肿瘤多药耐药性的关系

Expression of glucosylceramide synthase mRNA in vincristine-resistant KBV₂₀₀ cell line in association with multidrug resistance

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 9

编辑推荐

Metrics

本文评价

[1]	邹外一，许多荣，苏畅，陈媚，李娟，罗绍凯 . 动态观察慢性髓性白血病患者β-catenin 变化与细胞遗传学疗效的关系[J]. 南方医科大学学报, 2010, 30(08): 1868-1873.
[2]	任非, 杨西晓, 陈建海. 丝裂霉素C磁性纳米球对肝细胞L-02的细胞增殖和细胞凋亡的影响[J]. 南方医科大学学报, 2005, 25(12): 1485-1487.
[3]	崔斐, 罗荣城, 陈锦章, 陈斌, 黄宇贤. 紫杉醇联合Herceptin或表阿霉素治疗Her-2/neu阳性乳腺癌患者的临床疗效[J]. 南方医科大学学报, 2005, 25(12): 1533-1536.
[4]	杨西晓, 陈建海, 郭丹. 聚氰基丙烯酸正丁酯纳米粒的生物相容性研究[J]. 南方医科大学学报, 2005, 25(10): 1261-1263.
[5]	吕扬阳¹, 杨俊², 陈龙华¹. 小剂量吉西他滨可促进放疗致人肝癌细胞株SMMC-7721的凋亡[J]. 南方医科大学学报, 2005, 25(03): 301-304.
[6]	谢方明¹, 曾抗¹, 李国锋², 林中方¹, 孙乐栋¹. 鬼臼毒素硬脂酸固体脂质纳米粒的制备[J]. 南方医科大学学报, 2005, 25(01): 99-101.
[7]	孙明¹, 杨宇如¹, 李虹¹, 陈一戎², 王志平², 卢一平¹, 魏强¹, 岳中瑾². 紫杉醇和吉西他滨对激素非依赖性前列腺癌的作用[J]. 南方医科大学学报, 2004, 24(09): 1009-1012.
[8]	李亦蕾, 吴曙光. 洛拉曲克对胸苷酸合成酶蛋白质表达水平的动态影响[J]. 南方医科大学学报, 2004, 24(08): 881-884.
[9]	林中方¹, 曾抗¹, 周再高¹, 李国锋², 谢方明¹, 朱晓亮¹, 张三泉¹. 鬼臼毒素二棕榈酰磷脂酰胆碱前体脂质体的研制及特性观察[J]. 南方医科大学学报, 2004, 24(07): 784-786,788.